Results of the First-in-Human Clinical Trial for MB-102, a Novel Fluorescent Tracer Agent for Real-Time Measurement of Glomerular Filtration Rate

R.B. Dorshow, M.P. Debreczeny, and T.C. Dowling, “Results of the first-in-human clinical trial for MB-102, a novel fluorescent tracer agent for real-time measurement of glomerular filtration rate,” Reporters, Markers, Dyes, Nanoparticles, and Molecular Probes for Biomedical Applications VII, SPIE Proceedings Series 9339, 933906-1 (2015).